Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
NCT01841762
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
284
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
Macitentan
Sponsor
Actelion